Last reviewed · How we verify

NCT04942561

VR to Reduce Pain/Anxiety During IV Starts

Completed NA Last updated 1 July 2021
What this trial tests

NA trial testing Samsung Gear VR in Radiology in 107 participants. Completed in 24 July 2019.

Timeline
12 April 2017
Primary endpoint
24 July 2019
24 July 2019

Quick facts

Lead sponsorChildren's Hospital Los Angeles
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment107
Start date12 April 2017
Primary completion24 July 2019
Estimated completion24 July 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital Los Angeles

Who can join

Adults 10 to 21, any sex, with Radiology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to test the effectiveness of virtual reality (VR) as a non-pharmaceutical intervention to reduce pain and anxiety in children undergoing peripheral intravenous catheter (PIVC) access in the Department of Radiology and Imaging or the outpatient Infusion Center at CHLA, as measured by self- and proxy-report.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Samsung Gear VR

Trials testing the same drug.

Other recruiting trials for Radiology

Currently open trials in the same condition.

Other Children's Hospital Los Angeles trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04942561.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing